With over 70 challenge studies in our portfolio, we specialize in testing infectious and respiratory disease vaccines and therapeutics using human challenge trials. Our team of experts is dedicated to driving excellence and delivering innovative solutions for both pharmaceutical and biotech companies. Our range of services includes new challenge trials for diseases such as RSV, influenza, COVID-19, hMPV, HRV, malaria, asthma, and COPD.

We offer the only commercially validated human challenge models available to test the efficacy and effectiveness of vaccines and antivirals. In addition to challenge trials, we provide comprehensive laboratory services including assay development, field trial bio-logistics, cell-based assays, molecular services, compound efficacy, and VRM biomarker analysis. Our assays are developed and validated to the highest industry standards, ensuring accurate and reliable results.

Whether you're a potential customer, job seeker, health professional, or investor, hVIVO is here to help. Contact us today to discover how we can assist you in advancing medical research and understanding viral illnesses to a new level